{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T13:51:50Z","timestamp":1778939510252,"version":"3.51.4"},"reference-count":42,"publisher":"The Journal of Rheumatology","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>We previously reported the effect of certain factors on cardiovascular disease (CVD) in 250 women with systemic lupus erythematosus (SLE) followed for 8 years. The aim of this study was to delineate their evolution after 15 years of followup.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>There were 210 women with SLE and 138 age-matched healthy women available for analysis after 15 years. Cardiovascular events (CVE) included angina pectoris, myocardial infarction (fatal and nonfatal), transient ischemic attack, and stroke (fatal and nonfatal). Analysis was performed with SAS 9.3 software; p &lt; 0.05 was considered significant.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>CVE occurred in 41\/210 patients (19.5%) and 9\/138 controls (6.5%), most of them in the second part (2008\u20132015) of the study (24\/210, 11.4% vs 17\/241, 7.1% in SLE group). Coronary artery disease was more common in patients (32\/210, 15.2% vs 5\/138, 3.6%, p = 0.0041). There was no significant difference for cerebrovascular disease (10\/210, 4.8% vs 3\/138, 2.2%, p = 0.213). SLE was the most prominent CVE predictor in the first 8 years (HR 2.8, 95% CI 1.3\u20136.3). Hypertension and diabetes were more frequent in patients who developed CVE during the second half of the study. Thirty-one deaths occurred in patients with SLE (10 because of CVD) and 6 in controls (none because of CVD).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>The relative importance of atherosclerotic risk factors is significantly differentiated over time in SLE. Disease-related factors seem to dominate CV risk during the early stages while traditional factors, partially related to corticosteroid treatment, play a significant role later in the disease course.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.161121","type":"journal-article","created":{"date-parts":[[2017,11,2]],"date-time":"2017-11-02T00:12:05Z","timestamp":1509581525000},"page":"1841-1849","source":"Crossref","is-referenced-by-count":59,"title":["Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study"],"prefix":"10.3899","volume":"44","author":[{"given":"Konstantinos","family":"Tselios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dafna D.","family":"Gladman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiandong","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Ace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murray B.","family":"Urowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2262","published-online":{"date-parts":[[2017,11,1]]},"reference":[{"key":"2018112909375853000_44.12.1841.1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(76)90431-9"},{"key":"2018112909375853000_44.12.1841.2","first-page":"70","article-title":"Atherosclerotic vascular events in a single large lupus cohort: prevalence and risk factors","volume":"34","author":"Urowitz","year":"2007","journal-title":"J Rheumatol"},{"key":"2018112909375853000_44.12.1841.3","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009122"},{"key":"2018112909375853000_44.12.1841.4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(92)90578-Y"},{"key":"2018112909375853000_44.12.1841.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2005.01.001"},{"key":"2018112909375853000_44.12.1841.6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035471"},{"key":"2018112909375853000_44.12.1841.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035611"},{"key":"2018112909375853000_44.12.1841.8","doi-asserted-by":"publisher","DOI":"10.1161\/hc4101.097518"},{"key":"2018112909375853000_44.12.1841.9","doi-asserted-by":"publisher","DOI":"10.1136\/ard.62.11.1071"},{"key":"2018112909375853000_44.12.1841.10","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21782"},{"key":"2018112909375853000_44.12.1841.11","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150460"},{"key":"2018112909375853000_44.12.1841.12","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I"},{"key":"2018112909375853000_44.12.1841.13","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313493031"},{"key":"2018112909375853000_44.12.1841.14","doi-asserted-by":"publisher","DOI":"10.1002\/art.11296"},{"key":"2018112909375853000_44.12.1841.15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090011"},{"key":"2018112909375853000_44.12.1841.16","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400928"},{"key":"2018112909375853000_44.12.1841.17","doi-asserted-by":"publisher","DOI":"10.1002\/art.21955"},{"key":"2018112909375853000_44.12.1841.18","first-page":"713","article-title":"Cardiovascular disease a hazard despite improved prognosis in patients with systemic lupus erythematosus: results from a Swedish population based study 1964\u201395","volume":"31","author":"Bj\u00f6rn\u00e5dal","year":"2004","journal-title":"J Rheumatol"},{"key":"2018112909375853000_44.12.1841.19","first-page":"20","article-title":"Risk of myocardial infarction in patients with systemic lupus erythematosus: a population-based study","volume":"22","author":"Avina-Zubieta","year":"2013","journal-title":"Lupus"},{"key":"2018112909375853000_44.12.1841.20","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130874"},{"key":"2018112909375853000_44.12.1841.21","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.14"},{"key":"2018112909375853000_44.12.1841.22","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1177\/2047487314546826","article-title":"Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis","volume":"22","author":"Ballocca","year":"2015","journal-title":"Eur J Preven Cardiol"},{"key":"2018112909375853000_44.12.1841.23","doi-asserted-by":"publisher","DOI":"10.1177\/0961203311425524"},{"key":"2018112909375853000_44.12.1841.24","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309104862"},{"key":"2018112909375853000_44.12.1841.25","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110329"},{"key":"2018112909375853000_44.12.1841.26","doi-asserted-by":"publisher","DOI":"10.1186\/ar2878"},{"key":"2018112909375853000_44.12.1841.27","doi-asserted-by":"publisher","DOI":"10.1186\/ar3759"},{"key":"2018112909375853000_44.12.1841.28","unstructured":"Inanc M . Risk factors for non-fatal cardiovascular disease in systemic lupus erythematosus: multivariate analysis in a cohort of 306 patients [abstract]. Lupus 2013."},{"issue":"Suppl 10","key":"2018112909375853000_44.12.1841.29","first-page":"S319","article-title":"Does cigarette smoking affect disease phenotype in systemic lupus erythematosus [abstract]?","volume":"62","author":"Jolly","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2018112909375853000_44.12.1841.30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.111127"},{"key":"2018112909375853000_44.12.1841.31","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kws130"},{"key":"2018112909375853000_44.12.1841.32","doi-asserted-by":"publisher","DOI":"10.1186\/ar3473"},{"key":"2018112909375853000_44.12.1841.33","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep102"},{"key":"2018112909375853000_44.12.1841.34","doi-asserted-by":"publisher","DOI":"10.1191\/096120300669204787"},{"key":"2018112909375853000_44.12.1841.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.20622"},{"key":"2018112909375853000_44.12.1841.36","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker339"},{"key":"2018112909375853000_44.12.1841.37","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-008-0045-2"},{"key":"2018112909375853000_44.12.1841.38","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20122"},{"key":"2018112909375853000_44.12.1841.39","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1910-3"},{"key":"2018112909375853000_44.12.1841.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04211.x"},{"key":"2018112909375853000_44.12.1841.41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150983"},{"key":"2018112909375853000_44.12.1841.42","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0961203314526291","article-title":"Clinical manifestations and survival among adults with (SLE) according to age at diagnosis","volume":"23","author":"Merola","year":"2014","journal-title":"Lupus"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.161121","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T19:25:21Z","timestamp":1543519521000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.161121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,1]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,12,1]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.3899\/jrheum.161121"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.161121","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,1]]}}}